Literature DB >> 23462048

Abnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia.

Janusz Tucholski1, Micah S Simmons, Anita L Pinner, Vahram Haroutunian, Robert E McCullumsmith, James H Meador-Woodruff.   

Abstract

Numerous studies have demonstrated brain region- and subunit-specific abnormalities in the expression of subunits of the AMPA subtype of glutamate receptors in schizophrenia. In addition, abnormalities in the expression of proteins that regulate the forward trafficking of AMPA receptors through the cell have been reported. These findings suggest abnormal trafficking of AMPA receptors as a mechanism underlying dysregulated glutamate neurotransmission in schizophrenia. AMPA receptor subunits (GluR1-4) assemble to form AMPA receptor complexes in the lumen of the endoplasmic reticulum (ER). These subunits undergo the posttranslational modification of N-linked glycosylation in the ER and the Golgi apparatus before the assembled receptors are transported to the plasma membrane. In this study, we measured expression of AMPA receptors and the extent of their N-glycosylation using Western blot analysis in the dorsolateral prefrontal cortex in subjects with schizophrenia (N = 35) and a comparison group (N = 31). N-glycosylation was assessed using molecular mass shift assays following digestion with endoglycosidase H (Endo H), which removes immature high mannose-containing sugars, and with peptide-N-glycosidase F (PNGase F), which removes all N-linked sugars. Of the four AMPA receptor subunits, only GluR4 was significantly increased in schizophrenia. GluR2 and GluR4 were both sensitive to Endo H and PNGase F treatment. Endo H-mediated deglycosylation of GluR2 resulted in a significantly smaller pool of GluR2 protein to shift in schizophrenia, reflecting less N-linked high mannose and/or hybrid sugars on the GluR2 protein in this illness. This was confirmed by immunoisolation of GluR2 and probing with Concanavalin A, a mannose specific lectin; in subjects with schizophrenia GluR2 was significantly less reactive to Concanavalin A. Altered N-linked glycosylation of the GluR2 subunit in schizophrenia suggests abnormal trafficking of AMPA receptors from the ER to the synaptic membrane in schizophrenia. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23462048      PMCID: PMC3655690          DOI: 10.1016/j.schres.2013.01.031

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  47 in total

Review 1.  Glutamatergic mechanisms in schizophrenia.

Authors:  Guochuan Tsai; Joseph T Coyle
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002       Impact factor: 13.820

2.  Assessment of dementia in elderly schizophrenics with structured rating scales.

Authors:  P D Harvey; M Davidson; P Powchik; M Parrella; L White; R C Mohs
Journal:  Schizophr Res       Date:  1992-04       Impact factor: 4.939

3.  Use of lectins in analysis of glycoconjugates.

Authors:  R D Cummings
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

4.  Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex.

Authors:  K Mirnics; F A Middleton; A Marquez; D A Lewis; P Levitt
Journal:  Neuron       Date:  2000-10       Impact factor: 17.173

Review 5.  Recent advances in the phencyclidine model of schizophrenia.

Authors:  D C Javitt; S R Zukin
Journal:  Am J Psychiatry       Date:  1991-10       Impact factor: 18.112

6.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

Authors:  J H Krystal; L P Karper; J P Seibyl; G K Freeman; R Delaney; J D Bremner; G R Heninger; M B Bowers; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1994-03

7.  Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem.

Authors:  R Kerwin; S Patel; B Meldrum
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

8.  Severity of symptoms in chronically institutionalized geriatric schizophrenic patients.

Authors:  M Davidson; P D Harvey; P Powchik; M Parrella; L White; H Y Knobler; M F Losonczy; R S Keefe; S Katz; E Frecska
Journal:  Am J Psychiatry       Date:  1995-02       Impact factor: 18.112

9.  Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia.

Authors:  S L Eastwood; B McDonald; P W Burnet; J P Beckwith; R W Kerwin; P J Harrison
Journal:  Brain Res Mol Brain Res       Date:  1995-04

10.  Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers.

Authors:  C R Breese; R Freedman; S S Leonard
Journal:  Brain Res       Date:  1995-03-13       Impact factor: 3.252

View more
  33 in total

1.  Decreased protein S-palmitoylation in dorsolateral prefrontal cortex in schizophrenia.

Authors:  Anita L Pinner; Janusz Tucholski; Vahram Haroutunian; Robert E McCullumsmith; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2016-02-11       Impact factor: 4.939

2.  Two N-glycosylation Sites in the GluN1 Subunit Are Essential for Releasing N-methyl-d-aspartate (NMDA) Receptors from the Endoplasmic Reticulum.

Authors:  Katarina Lichnerova; Martina Kaniakova; Seung Pyo Park; Kristyna Skrenkova; Ya-Xian Wang; Ronald S Petralia; Young Ho Suh; Martin Horak
Journal:  J Biol Chem       Date:  2015-06-04       Impact factor: 5.157

3.  Altered fucosyltransferase expression in the superior temporal gyrus of elderly patients with schizophrenia.

Authors:  Toni M Mueller; Stefani D Yates; Vahram Haroutunian; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2016-10-20       Impact factor: 4.939

4.  Loss of α1,6-Fucosyltransferase Decreases Hippocampal Long Term Potentiation: IMPLICATIONS FOR CORE FUCOSYLATION IN THE REGULATION OF AMPA RECEPTOR HETEROMERIZATION AND CELLULAR SIGNALING.

Authors:  Wei Gu; Tomohiko Fukuda; Tomoya Isaji; Qinglei Hang; Ho-hsun Lee; Seiichiro Sakai; Jyoji Morise; Junya Mitoma; Hideyoshi Higashi; Naoyuki Taniguchi; Hiromu Yawo; Shogo Oka; Jianguo Gu
Journal:  J Biol Chem       Date:  2015-05-15       Impact factor: 5.157

5.  Abnormal expression of ER quality control and ER associated degradation proteins in the dorsolateral prefrontal cortex in schizophrenia.

Authors:  Pitna Kim; Madeline R Scott; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2018-02-26       Impact factor: 4.939

6.  Thorase variants are associated with defects in glutamatergic neurotransmission that can be rescued by Perampanel.

Authors:  George K E Umanah; Marco Pignatelli; Xiling Yin; Rong Chen; Joshua Crawford; Stewart Neifert; Leslie Scarffe; Adam A Behensky; Noah Guiberson; Melissa Chang; Erica Ma; Jin Wan Kim; Cibele C Castro; Xiaobo Mao; Li Chen; Shaida A Andrabi; Mikhail V Pletnikov; Ann E Pulver; Dimitrios Avramopoulos; Antonello Bonci; David Valle; Ted M Dawson; Valina L Dawson
Journal:  Sci Transl Med       Date:  2017-12-13       Impact factor: 17.956

7.  Dysregulation of the unfolded protein response (UPR) in the dorsolateral prefrontal cortex in elderly patients with schizophrenia.

Authors:  Pitna Kim; Madeline R Scott; James H Meador-Woodruff
Journal:  Mol Psychiatry       Date:  2019-10-02       Impact factor: 15.992

Review 8.  Aberrant glycosylation in schizophrenia: a review of 25 years of post-mortem brain studies.

Authors:  Sarah E Williams; Robert G Mealer; Edward M Scolnick; Jordan W Smoller; Richard D Cummings
Journal:  Mol Psychiatry       Date:  2020-05-13       Impact factor: 15.992

Review 9.  Postmortem brain: an underutilized substrate for studying severe mental illness.

Authors:  Robert E McCullumsmith; John H Hammond; Dan Shan; James H Meador-Woodruff
Journal:  Neuropsychopharmacology       Date:  2013-10-04       Impact factor: 7.853

10.  Unconventional secretory processing diversifies neuronal ion channel properties.

Authors:  Cyril Hanus; Helene Geptin; Georgi Tushev; Sakshi Garg; Beatriz Alvarez-Castelao; Sivakumar Sambandan; Lisa Kochen; Anne-Sophie Hafner; Julian D Langer; Erin M Schuman
Journal:  Elife       Date:  2016-09-28       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.